查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1418431

皮灰指甲治療市場報告：2030 年趨勢、預測與競爭分析

Dermatophytic Onychomycosis Treatment Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 - page report | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

皮灰指甲治療的趨勢與預測

到 2030 年，全球皮灰指甲治療市場預計將達到 45 億美元，2024 年至 2030 年複合年成長率為 4.5%。這個市場的主要促進因素是由於灰指甲患者數量的增加、老年人口的增加、研究的不斷增加、指甲油的快速普及以及新學名藥的快速推出而導致甲癬發病率的增加。全球皮癬菌灰指甲治療市場的未來看起來充滿希望，處方藥和成藥藥市場都有機會。

皮癬菌灰指甲治療市場洞察

Lucintel 預測，由於 Jubria 的採用率不斷提高，指甲彩繪將在預測期內繼續成為較大的細分市場。

在這個市場中，成藥仍將是一個很大的細分市場，環吡酮的銷售將激增。

由於甲癬治療處方數量不斷增加，北美仍是預測期內最大的地區。

常問問題

Q1.市場規模有多大？

A1. 到 2030 年，全球皮癬菌甲癬治療市場預計將達到 45 億美元。

Q2.市場成長預測如何？

A2. 2024年至2030年，全球皮癬菌甲癬治療市場預計將以4.5%的複合年成長率成長。

Q3.影響市場成長的主要促進因素有哪些？

A3. 該市場的主要促進因素是糖尿病發病率的增加、老年人口的增加、研究的不斷增加、指甲油的迅速普及以及新學名藥的快速推出，導致指甲真菌感染疾病的發病率不斷增加。

Q4.市場的主要細分市場是什麼？

A4. 皮癬菌灰指甲藥物市場前景廣闊，處方藥和成藥市場都有機會。

Q5. 市場上主要企業有哪些？

A5. 生產甲癬治療藥物的主要企業如下。

  • Bausch Health Companies
  • Pfizer
  • Galderma
  • GlaxoSmithKline
  • Janssen Pharmaceuticals
  • Cipla
  • Kaken Pharmaceuticals

Q6.未來最大的細分市場是什麼？

A6.Lucintel 預計，由於 Jublia 的採用率不斷提高，指甲油在預測期內仍將佔據更大的市場佔有率。

Q7. 未來五年預計哪個地區將成為最大的市場？

A7. 由於甲癬治療處方數量的增加，北美在預測期內仍將是最大的地區。

Q8. 可以客製化報告嗎？

A8. 是的，Lucintel 提供 10% 的客製化服務，無需額外付費。

目錄

第1章執行摘要

第2章全球皮癬菌灰指甲治療市場：市場動態

  • 簡介、背景、分類
  • 供應鏈
  • 產業促進因素與挑戰

第3章 2018-2030年市場趨勢及預測分析

  • 宏觀經濟趨勢（2018-2023）與預測（2024-2030）
  • 全球皮膚絲狀菌症灰指甲治療市場趨勢（2018-2023）和預測（2024-2030）
  • 全球皮癬菌灰指甲治療市場，依產品類型
    • 藥片
    • 指甲油
  • 全球皮癬菌灰指甲治療市場，依給藥途徑
    • 口服
    • 局部的
  • 全球皮癬菌灰指甲治療市場，依類型
    • 指定的
    • 在商店
  • 全球皮癬菌灰指甲治療市場，依銷售管道
    • 醫院藥房
    • 零售藥房
    • 線上通路

第4章 2018-2030年區域市場趨勢及預測分析

  • 全球皮膚絲狀菌症灰指甲治療市場（按地區）
  • 北美皮癬菌灰指甲治療市場
  • 歐洲皮癬菌灰指甲治療市場
  • 亞太皮皮膚絲狀菌症灰指甲治療市場
  • 其他地區皮癬菌灰指甲治療市場

第5章 競爭分析

  • 產品系列分析
  • 營運整合
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
    • 按產品類型分類的全球皮癬菌灰指甲治療市場成長機會
    • 按途徑的全球皮灰指甲治療市場成長機會
    • 全球皮灰指甲治療市場成長機會（按類型）
    • 全球皮灰指甲治療市場成長機會（按分銷管道）
    • 全球皮灰指甲治療市場按地區成長機會
  • 全球皮灰指甲治療市場的新趨勢
  • 戰略分析
    • 新產品開發
    • 擴大全球皮癬菌灰指甲治療市場的產能
    • 全球皮癬菌灰指甲治療市場的合併、收購與合資
    • 認證和許可

第7章主要企業概況

  • Bausch Health Companies
  • Pfizer
  • Galderma
  • GlaxoSmithKline
  • Janssen Pharmaceuticals
  • Cipla
  • Kaken Pharmaceuticals
簡介目錄

Dermatophytic Onychomycosis Treatment Trends and Forecast

The future of the global dermatophytic onychomycosis treatment market looks promising with opportunities in the prescribed and over-the-counter markets. The global dermatophytic onychomycosis treatment market is expected to reach an estimated $4.5 billion by 2030 with a CAGR of 4.5% from 2024 to 2030. The major drivers for this market are increased incidence of nail fungal infections is caused by the rising frequency of diabetes, growing number of elderly people, and growing research, the quick uptake of nail polish, and the surge in the introduction of new generic medication.

A more than 150-page report is developed to help in your business decisions.

Dermatophytic Onychomycosis Treatment by Segment

The study includes a forecast for the global dermatophytic onychomycosis treatment by product type, route of administration, type, distribution channel, and region.

Dermatophytic Onychomycosis Treatment Market by Product Type [Shipment Analysis by Value from 2018 to 2030]:

  • Tablets
  • Nail Paints

Dermatophytic Onychomycosis Treatment Market by Route of Administration [Shipment Analysis by Value from 2018 to 2030]:

  • Oral
  • Topical

Dermatophytic Onychomycosis Treatment Market by Type [Shipment Analysis by Value from 2018 to 2030]:

  • Prescribed
  • Over-The-Counter

Dermatophytic Onychomycosis Treatment Market by Distribution Channel [Shipment Analysis by Value from 2018 to 2030]:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Channels

Dermatophytic Onychomycosis Treatment Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Dermatophytic Onychomycosis Treatment Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies dermatophytic onychomycosis treatment companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the dermatophytic onychomycosis treatment companies profiled in this report include-

  • Bausch Health Companies
  • Pfizer
  • Galderma
  • GlaxoSmithKline
  • Janssen Pharmaceuticals
  • Cipla
  • Kaken Pharmaceuticals

Dermatophytic Onychomycosis Treatment Market Insights

Lucintel forecasts that nail paints will remain the larger segment over the forecast period due to increasing adoption of jublia.

Within this market, over-the-counter will remain the larger segment due to rapidly increasing ciclopirox sales.

North America will remain the largest region over the forecast period due to rising count of prescriptions for onychomycosis treatment.

Features of the Global Dermatophytic Onychomycosis Treatment Market

Market Size Estimates: Dermatophytic onychomycosis treatment market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Dermatophytic onychomycosis treatment market size by various segments, such as by product type, route of administration, type, distribution channel, and region in terms of value ($B).

Regional Analysis: Dermatophytic onychomycosis treatment market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product type, route of administration, type, distribution channel, and regions for the dermatophytic onychomycosis treatment market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the dermatophytic onychomycosis treatment market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the dermatophytic onychomycosis treatment market size?

Answer: The global dermatophytic onychomycosis treatment market is expected to reach an estimated $4.5 billion by 2030.

Q2. What is the growth forecast for dermatophytic onychomycosis treatment market?

Answer: The global dermatophytic onychomycosis treatment market is expected to grow with a CAGR of 4.5% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the dermatophytic onychomycosis treatment market?

Answer: The major drivers for this market are increased incidence of nail fungal infections is caused by the rising frequency of diabetes, growing number of elderly people, and growing research, the quick uptake of nail polish, and the surge in the introduction of new generic medication.

Q4. What are the major segments for dermatophytic onychomycosis treatment market?

Answer: The future of the dermatophytic onychomycosis treatment market looks promising with opportunities in the prescribed and over-the-counter markets.

Q5. Who are the key dermatophytic onychomycosis treatment market companies?

Answer: Some of the key dermatophytic onychomycosis treatment companies are as follows.

  • Bausch Health Companies
  • Pfizer
  • Galderma
  • GlaxoSmithKline
  • Janssen Pharmaceuticals
  • Cipla
  • Kaken Pharmaceuticals

Q6. Which dermatophytic onychomycosis treatment market segment will be the largest in future?

Answer: Lucintel forecasts that nail paints will remain the larger segment over the forecast period due to increasing adoption of jublia.

Q7. In dermatophytic onychomycosis treatment market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to rising count of prescriptions for onychomycosis treatment.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the dermatophytic onychomycosis treatment market by product type (tablets and nail paints), route of administration (oral and topical), type (prescribed and over-the-counter), distribution channel (hospital pharmacies, retail pharmacies, and online channels), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Dermatophytic Onychomycosis Treatment Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Dermatophytic Onychomycosis Treatment Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Dermatophytic Onychomycosis Treatment Market by Product Type
    • 3.3.1: Tablets
    • 3.3.2: Nail Paints
  • 3.4: Global Dermatophytic Onychomycosis Treatment Market by Route of Administration
    • 3.4.1: Oral
    • 3.4.2: Topical
  • 3.5: Global Dermatophytic Onychomycosis Treatment Market by Type
    • 3.5.1: Prescribed
    • 3.5.2: Over-the-Counter
  • 3.6: Global Dermatophytic Onychomycosis Treatment Market by Distribution Channel
    • 3.6.1: Hospital Pharmacies
    • 3.6.2: Retail Pharmacies
    • 3.6.3: Online Channels

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Dermatophytic Onychomycosis Treatment Market by Region
  • 4.2: North American Dermatophytic Onychomycosis Treatment Market
    • 4.2.2: North American Dermatophytic Onychomycosis Treatment Market by Type: Prescribed and Over-the-Counter
  • 4.3: European Dermatophytic Onychomycosis Treatment Market
    • 4.3.1: European Dermatophytic Onychomycosis Treatment Market by Product Type: Tablets and Nail Paints
    • 4.3.2: European Dermatophytic Onychomycosis Treatment Market by Type: Prescribed and Over-the-Counter
  • 4.4: APAC Dermatophytic Onychomycosis Treatment Market
    • 4.4.1: APAC Dermatophytic Onychomycosis Treatment Market by Product Type: Tablets and Nail Paints
    • 4.4.2: APAC Dermatophytic Onychomycosis Treatment Market by Type: Prescribed and Over-the-Counter
  • 4.5: ROW Dermatophytic Onychomycosis Treatment Market
    • 4.5.1: ROW Dermatophytic Onychomycosis Treatment Market by Product Type: Tablets and Nail Paints
    • 4.5.2: ROW Dermatophytic Onychomycosis Treatment Market by Type: Prescribed and Over-the-Counter

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Dermatophytic Onychomycosis Treatment Market by Product Type
    • 6.1.2: Growth Opportunities for the Global Dermatophytic Onychomycosis Treatment Market by Route of Administration
    • 6.1.3: Growth Opportunities for the Global Dermatophytic Onychomycosis Treatment Market by Type
    • 6.1.4: Growth Opportunities for the Global Dermatophytic Onychomycosis Treatment Market by Distribution Channel
    • 6.1.5: Growth Opportunities for the Global Dermatophytic Onychomycosis Treatment Market by Region
  • 6.2: Emerging Trends in the Global Dermatophytic Onychomycosis Treatment Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Dermatophytic Onychomycosis Treatment Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Dermatophytic Onychomycosis Treatment Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Bausch Health Companies
  • 7.2: Pfizer
  • 7.3: Galderma
  • 7.4: GlaxoSmithKline
  • 7.5: Janssen Pharmaceuticals
  • 7.6: Cipla
  • 7.7: Kaken Pharmaceuticals